Recursion Pharmaceuticals, Inc. (RXRX) vs Viridian Therapeutics, Inc. (VRDN)
- Recursion Pharmaceuticals, Inc. RXRX 3.47 −16.59%
- Viridian Therapeutics, Inc. VRDN 19.03 −2.71%
Recursion Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. are both Biotechnology companies. Recursion Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. are of similar size ($2.2B and $2.2B). Viridian Therapeutics, Inc. grew revenue faster over the last twelve months: 23,220.3% against −15.1%. Viridian Therapeutics, Inc. has the higher net margin (−544.1% vs −945.9%) and the higher return on invested capital (0.00% vs −92.2%). Across the 18 metrics below, Viridian Therapeutics, Inc. leads on 12 and Recursion Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | RXRX | VRDN | Biotechnology median |
|---|---|---|---|
| Gross margin | 3.48% | 100.00% | 65.16% |
| Operating margin | (991.72%) | (569.68%) | 0.00% |
| Net margin | (945.92%) | (544.06%) | 0.00% |
| Free cash flow margin | (645.82%) | (471.04%) | 0.00% |
| Return on equity | (56.58%) | (86.93%) | (56.36%) |
| Return on assets | (41.26%) | (46.08%) | (48.04%) |
| Return on invested capital | (92.22%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack